At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients
In Brief
A clinical study evaluating mHealth intervention and standard of care for Medication Adherence and 2 related conditions. Completed, enrolled 75 participants across 2 sites.
Detailed Summary
In solid organ transplant recipients, poor adherence to immunosuppressant medications carries the risk of graft rejection (needing a new transplant), post-transplant complications, and increased healthcare costs. Additionally, nonadherence to immunosuppressant medications is imperative to short- and long-term outcomes. The rate of nonadherence in this population varies vastly. Because of lacking objective and accurate nonadherence measurements, both to immunosuppressant drugs and medical indications, the true implications and prevalence of nonadherence is not yet well understood. Therefore, investigators believe that mobile health (mHealth) technology has the potential to allow clinicians and researchers to more comprehensively address and understand nonadherence in solid organ transplant recipients. The aim of this study is to conduct a randomized control trial to compare medication adherence among liver and kidney transplant patients who use the mHealth system against controls who do not.
Study Details
Timeline
Interventions
Subjects will receive mHealth direct observation of therapy for 12 weeks
Subjects will receive standard of care observation for 12 weeks